九源基因(02566)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02566 九源基因

农历年初一休市 02-16 12:08:04

9.580

-0.010

-0.10%

最高9.590	最低9.390	成交量2.44万
今开9.590	昨收9.590	日振幅2.09%
总市值23.18亿	流通市值10.15亿	总股本2.42亿
成交额22.97万	换手率0.02%	流通股本1.06亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02566","market":"HK","secType":"STK","nameCN":"九源基因","latestPrice":9.58,"timestamp":1771214884583,"preClose":9.59,"halted":0,"volume":24400,"delay":0,"changeRate":-0.0010427528675703635,"floatShares":106000000,"shares":242000000,"eps":0.678655,"marketStatus":"农历年初一休市","change":-0.01,"latestTime":"02-16 12:08:04","open":9.59,"high":9.59,"low":9.39,"amount":229746,"amplitude":0.020855,"askPrice":9.59,"askSize":1000,"bidPrice":9.34,"bidSize":2200,"shortable":0,"etf":0,"ttmEps":0.559,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1771551000000},"marketStatusCode":7,"adr":0,"listingDate":1732723200000,"exchange":"SEHK","adjPreClose":9.59,"dividendRate":0.006583,"openAndCloseTimeList":[[1771205400000,1771214400000]],"volumeRatio":0.2952695269039709,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02566/wiki","defaultTab":"wiki","newsList":[{"id":"2610794209","title":"九源基因(02566)2月12日耗资约25.53万港元回购2.6万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2610794209","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610794209?lang=zh_cn&edition=full","pubTime":"2026-02-12 19:03","pubTimestamp":1770894192,"startTime":"0","endTime":"0","summary":"智通财经APP讯，九源基因(02566)公布，2026年2月12日耗资约25.53万港元回购2.6万股股份。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1404787.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02566","BK1161"],"gpt_icon":0},{"id":"2610936857","title":"九源基因(02566)2月11日斥资8.51万港元回购8600股","url":"https://stock-news.laohu8.com/highlight/detail?id=2610936857","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610936857?lang=zh_cn&edition=full","pubTime":"2026-02-11 18:54","pubTimestamp":1770807244,"startTime":"0","endTime":"0","summary":"智通财经APP讯，九源基因(02566)发布公告，该公司于2026年2月11日斥资8.51万港元回购8600股股份，每股回购价格为9.89-9.9港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1404271.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02566"],"gpt_icon":0},{"id":"1103066878","title":"杭州九源基因(02566)回购约28.52万股H股，总额约287万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1103066878","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1103066878?lang=zh_cn&edition=full","pubTime":"2026-02-10 19:01","pubTimestamp":1770721311,"startTime":"0","endTime":"0","summary":"杭州九源基因生物医药股份有限公司(02566)于2026年2月10日发布翌日披露报表，披露当日回购285,200股H股，占回购前公司已发行股份（不包括库藏股）的约0.27024%。\n本次回购于香港联交所进行，价格区间介于每股9.83港元至10.30港元之间，合计支付约2,870,506.048港元。根据2025年6月11日获通过的购回授权，公司剩余可回购股份数为10,909,678股。回购完成后，公司已发行股份总数维持在109,096,785股，其中流通股为105,248,985股，库藏股为3,847,800股。\n公司确认已严格遵守相关上市规则及法律规定。公告由联席公司秘书黄秀签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02566"],"gpt_icon":0},{"id":"2610756637","title":"九源基因(02566)2月9日斥资60.59万港元回购6.08万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2610756637","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610756637?lang=zh_cn&edition=full","pubTime":"2026-02-09 20:13","pubTimestamp":1770639185,"startTime":"0","endTime":"0","summary":"智通财经APP讯，九源基因(02566)发布公告，于2026年2月9日，该公司斥资60.59万港元回购6.08万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1403330.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02566"],"gpt_icon":0},{"id":"1194403275","title":"杭州九源基因（02566）回购6.08万股股份，总额约60.59万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1194403275","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1194403275?lang=zh_cn&edition=full","pubTime":"2026-02-09 19:51","pubTimestamp":1770637908,"startTime":"0","endTime":"0","summary":"杭州九源基因生物医药股份有限公司于2026年2月9日公布翌日披露报表，披露当日回购60,800股H股股份，约占回购前已发行股本的0.05758%。本次回购每股价格在每股港币9.81元至10元区间，总额约港币60.59万元。据公告显示，本次回购基于2025年6月11日通过的回购授权进行，公司目前可回购股份总数为10,909,678股，截至公告日已回购3,562,600股。公司确认已遵守香港联合交易所有限公司证券上市规则及相关法律规定。公告由联席公司秘书黄秀签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02566"],"gpt_icon":0},{"id":"2610600638","title":"九源基因(02566)：JY54注射液IND申请获CDE正式受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2610600638","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610600638?lang=zh_cn&edition=full","pubTime":"2026-02-09 16:56","pubTimestamp":1770627414,"startTime":"0","endTime":"0","summary":"智通财经APP讯，九源基因 发布公告，公司自主开发的化学1类创新药JY54 注射液新药临床试验申请，已获国家药品监督管理局药品审评中心正式受理。JY54注射液是公司自主研发的一款长效胰淀素类似物。此外，在与已上市肥胖治疗药物的联合应用研究中，JY54注射液展现出显著的药物协同潜力。基于其分子设计特点及作用机制分析，JY54注射液有望支持长效给药方案，并在体重管理领域展现差异化的临床应用潜力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1403166.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1223082196.USD","BK1161","IND","02566","BK4017","CDE","LU1223083913.SGD","LU1223082519.USD"],"gpt_icon":0},{"id":"1111776355","title":"九源基因Jy54注射液临床试验申请获国家药监局药品审评中心受理","url":"https://stock-news.laohu8.com/highlight/detail?id=1111776355","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111776355?lang=zh_cn&edition=full","pubTime":"2026-02-09 16:53","pubTimestamp":1770627193,"startTime":"0","endTime":"0","summary":"杭州九源基因工程股份有限公司宣布，其研发的Jy54注射液新药临床试验（IND）申请，已正式获得国家药品监督管理局药品审评中心（CDE）的受理。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02566"],"gpt_icon":0},{"id":"1186606364","title":"杭州九源基因（02566）回购7.92万股H股，涉资约79万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1186606364","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1186606364?lang=zh_cn&edition=full","pubTime":"2026-02-06 19:33","pubTimestamp":1770377612,"startTime":"0","endTime":"0","summary":"杭州九源基因生物医药股份有限公司（02566）于2026年2月6日发布公告，披露当日回购H股79,200股，占回购前已发行股份的约0.07495%。本次回购价格介乎每股9.88港元至10港元，合计支付约790,449.98港元。\n经本次回购后，公司已发行股份（不包括库存股份）数目变更为105,594,985股，库存股份增至3,501,800股。公司于2025年6月11日通过的购回授权总数为10,909,678股，截至目前已回购股份合计3,501,800股。\n公司确认本次回购已依据董事会授权，并遵守香港联合交易所有限公司证券上市规则及相关法律法规。公告由联席公司秘书黄秀签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02566"],"gpt_icon":0},{"id":"2609737452","title":"九源基因(02566.HK)2月5日耗资877.3万港元回购85.4万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2609737452","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609737452?lang=zh_cn&edition=full","pubTime":"2026-02-05 19:47","pubTimestamp":1770292023,"startTime":"0","endTime":"0","summary":"格隆汇2月5日丨九源基因(02566.HK)公告，2月5日耗资877.3万港元回购85.4万股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260205/32001587.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1161","02566"],"gpt_icon":0},{"id":"1177717368","title":"杭州九源基因(02566)回购854,000股H股，总额约877万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1177717368","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1177717368?lang=zh_cn&edition=full","pubTime":"2026-02-05 19:15","pubTimestamp":1770290133,"startTime":"0","endTime":"0","summary":"杭州九源基因生物医药股份有限公司于2026年2月5日发布翌日披露报表，公告公司在联交所进行H股回购。根据公告，此次回购股份数为854,000股，占此前已发行股份总数约0.80167%。回购最高价每股10.50港元，最低价每股9.69港元，涉资约8,773,092港元。公司于2025年6月11日获得股东大会批准的回购授权，可购回最多10,909,678股，截至目前已累计回购3,422,600股，占授权通过时已发行股份总数的约3.13721%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02566"],"gpt_icon":0},{"id":"2609465503","title":"九源基因盘中异动 早盘股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609465503","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609465503?lang=zh_cn&edition=full","pubTime":"2026-02-05 10:02","pubTimestamp":1770256944,"startTime":"0","endTime":"0","summary":"2026年02月05日早盘10时02分，九源基因股票出现异动，股价急速上涨5.00%。截至发稿，该股报10.500港元/股，成交量41.42万股，换手率0.39%，振幅9.80%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。九源基因股票所在的药品行业中，整体涨幅为0.17%。其相关个股中，四环医药、九源基因、先声药业涨幅较大，振幅较大的相关个股有德琪医药-B、九源基因、君圣泰医药-B，振幅分别为17.71%、8.30%、6.57%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260205100225a47df888&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260205100225a47df888&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02566"],"gpt_icon":0},{"id":"1197270440","title":"杭州九源基因（02566）回购68万股股份，总额约726万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1197270440","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1197270440?lang=zh_cn&edition=full","pubTime":"2026-02-04 19:26","pubTimestamp":1770204367,"startTime":"0","endTime":"0","summary":"杭州九源基因生物医药股份有限公司于2026年2月4日根据购回授权在香港联交所购回680,400股H股，每股购回价格介乎每股9.81港元至10.74港元，涉资约7,259,382.17港元，占购回前公司已发行股份总数约0.63%。公司购回授权于2025年6月11日获通过，可回购股份总数为10,909,678股，已累计回购2,568,600股。公司确认已遵守香港联交所上市规则及相关法规的要求，并已履行必要的法律和程序。公告由联席公司秘书黄秀签署，日期为2026年2月4日。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02566"],"gpt_icon":0},{"id":"2608363026","title":"九源基因(02566)2月4日斥资725.94万港元回购68.04万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2608363026","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608363026?lang=zh_cn&edition=full","pubTime":"2026-02-04 19:24","pubTimestamp":1770204255,"startTime":"0","endTime":"0","summary":"智通财经APP讯，九源基因(02566)发布公告，该公司于2026年2月4日斥资725.94万港元回购68.04万股股份，每股回购价格为9.81-10.74港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1401700.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02566","BK1161"],"gpt_icon":0},{"id":"1176944137","title":"杭州九源基因（02566）2026年1月股份变动月报：回购774,400股并存为库存","url":"https://stock-news.laohu8.com/highlight/detail?id=1176944137","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1176944137?lang=zh_cn&edition=full","pubTime":"2026-02-04 16:37","pubTimestamp":1770194249,"startTime":"0","endTime":"0","summary":"杭州九源基因生物医药股份有限公司于2026年2月4日披露2026年1月股份变动月报表，报告期截至1月31日。公告显示，公司注册股本仍为人民币245,398,800元，分为H股、内资股及非上市外资股三类，其中H股注册股数为109,096,785股，内资股105,302,015股，非上市外资股31,000,000股，均无增减变动。根据月报，公司当月主要进行了H股的股份回购操作。截至报告期末，公司股本总数保持在109,096,785股，其中108,322,385股为已发行流通股，774,400股为库存股。本次月报由联席公司秘书黄秀签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02566"],"gpt_icon":0},{"id":"2608866322","title":"九源基因(02566)2月2日斥资613.97万港元回购57.54万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2608866322","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608866322?lang=zh_cn&edition=full","pubTime":"2026-02-02 20:07","pubTimestamp":1770034051,"startTime":"0","endTime":"0","summary":"九源基因(02566)发布公告，于2026年2月2日斥资613.97万港元回购57.54万股。","market":"hk","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_42.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_42.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1400713.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["02566","BK1161"],"gpt_icon":0},{"id":"2607194017","title":"九源基因(02566)1月30日耗资约143.64万港元回购13.66万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2607194017","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607194017?lang=zh_cn&edition=full","pubTime":"2026-01-30 19:58","pubTimestamp":1769774317,"startTime":"0","endTime":"0","summary":"智通财经APP讯，九源基因(02566)公布，2026年1月30日耗资约143.64万港元回购13.66万股股份。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1400009.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02566","BK1161"],"gpt_icon":0},{"id":"2607086352","title":"九源基因(02566)1月29日斥资159.43万港元回购15.4万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2607086352","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607086352?lang=zh_cn&edition=full","pubTime":"2026-01-29 19:19","pubTimestamp":1769685577,"startTime":"0","endTime":"0","summary":"智通财经APP讯，九源基因(02566)发布公告，于2026年1月29日，该公司斥资159.43万港元回购15.4万股股份。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1399305.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02566"],"gpt_icon":0},{"id":"2607691990","title":"九源基因01月29日获主力加仓38.4万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2607691990","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607691990?lang=zh_cn&edition=full","pubTime":"2026-01-29 16:15","pubTimestamp":1769674514,"startTime":"0","endTime":"0","summary":"01月29日, 九源基因股价涨0.68%，报收10.33元，成交金额311.0万元，换手率0.28%，振幅2.63%，量比2.01。九源基因今日主力资金净流入38.4万元，上一交易日主力净流入18.4万元。该股近5个交易日上涨8.11%，主力资金累计净流入39.8万元；近20日主力资金累计净流入247.8万元，其中净流入天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129161603a463d013&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129161603a463d013&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02566","BK1161"],"gpt_icon":0},{"id":"2606792385","title":"九源基因(02566)1月28日耗资约113.55万港元回购11.14万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2606792385","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606792385?lang=zh_cn&edition=full","pubTime":"2026-01-28 18:07","pubTimestamp":1769594823,"startTime":"0","endTime":"0","summary":"智通财经APP讯，九源基因(02566)公布，2026年1月28日耗资约113.55万港元回购11.14万股股份。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1398618.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02566","BK1161"],"gpt_icon":0},{"id":"2606462769","title":"九源基因01月27日主力净流出17.0万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2606462769","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606462769?lang=zh_cn&edition=full","pubTime":"2026-01-27 16:15","pubTimestamp":1769501739,"startTime":"0","endTime":"0","summary":"01月27日, 九源基因股价跌0.30%，报收10.04元，成交金额69.9万元，换手率0.06%，振幅1.59%，量比0.35。九源基因今日主力资金净流出17.0万元，上一交易日主力净流出0万元。该股近5个交易日上涨8.83%，主力资金累计净流入53.2万元；近20日主力资金累计净流入148.5万元，其中净流入天数为7日。该股主力净额占比0.02%，港股市场排名2417/2708。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127161925a45b26b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127161925a45b26b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02566"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.china-gene.com","stockEarnings":[{"period":"1week","weight":-0.042},{"period":"1month","weight":0.0752},{"period":"3month","weight":0.355},{"period":"6month","weight":-0.3937},{"period":"1year","weight":0.5414},{"period":"ytd","weight":0.2672}],"compareEarnings":[{"period":"1week","weight":-0.0119},{"period":"1month","weight":-0.0052},{"period":"3month","weight":0.0299},{"period":"6month","weight":0.0612},{"period":"1year","weight":0.1806},{"period":"ytd","weight":0.042}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"杭州九源基因生物医药股份有限公司（原名：杭州九源基因工程股份有限公司）是一家主要从事研发、生产及商业化生物药品和医疗器械的中国公司。该公司专注于骨科、代谢疾病、肿瘤及血液治疗领域。该公司的骨科产品包括骨优导骨修复材料。该公司的肿瘤产品包括吉利芬、吉巨芬、吉欧停、吉芙惟、吉坦苏。该公司的血液产品包括吉派林、亿喏佳。该公司的产品主要用于治疗糖尿病、多发性骨髓瘤、血小板减少症、中性粒细胞减少症等疾病。该公司主要在中国国内和海外市场开展业务。","exchange":"SEHK","name":"九源基因","nameEN":"JIUYUAN GENE"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"九源基因(02566)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供九源基因(02566)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"九源基因,02566,九源基因股票,九源基因股票老虎,九源基因股票老虎国际,九源基因行情,九源基因股票行情,九源基因股价,九源基因股市,九源基因股票价格,九源基因股票交易,九源基因股票购买,九源基因股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"九源基因(02566)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供九源基因(02566)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}